Figure 2From: A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma Kaplan-Meier analysis of local recurrence, overall survival (OS) and disease-free survival (DFS). Back to article page